CTI BIOPHARMA CORP Quarterly Operating Lease, Liability, Current in USD from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Cti Biopharma Corp quarterly Operating Lease, Liability, Current history and growth rate from Q4 2018 to Q1 2023.
  • Cti Biopharma Corp Operating Lease, Liability, Current for the quarter ending March 31, 2023 was $811K, a 1.34% decline year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $811K -$11K -1.34% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $781K -$379K -32.7% Dec 31, 2022 10-Q 2023-05-15
Q1 2022 $822K -$1.46M -63.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.16M -$1.03M -47.1% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $1.38M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.94M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $2.28M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $2.19M +$241K +12.3% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $1.95M +$1.95M Dec 31, 2019 10-K 2020-03-13
Q3 2019 $1.89M Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $1.82M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.75M Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.